CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico
Summary The analyst has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico".The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico.
It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Mexico.Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.
It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by ourteam of industry experts.
Scope The report provides information on the healthcare, regulatory, and reimbursement landscape in the Mexico, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Boehringer Ingelheim, Bayer, Pfizer, GSK, and Genomma Lab) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, Essilor, Zimmer Biomet and Abbott)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Mexico
- Porter’s five forces analysis for pharmaceutical and medical devices market of Mexico
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Mexican healthcare market.
Reasons to buy This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Mexican healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Mexican healthcare market.
Our reports have been used by over 10K customers, including:
The European Pharmaceutical Logistics Market is expected to grow at a CAGR of more than 4% during the forecast period. The market growth can be seen as a result of Covid-19, with an increase in pharmaceutical product imports (USD 361 billion) and exports (USD 524 billion) in the year 2020. Logistics is an essential segment of supply...
The global pharmaceutical CMO market was valued at USD 120.29 billion in 2020, and it is expected to reach USD 195.70 billion by 2026, registering a CAGR of 7.85% from 2021 to 2026. COVID-19 pandemic has had a beneficial effect on contract manufacturing services overall. There were multiple opportunities for CMOs in clinical trial manufacturing,...
The pharmaceutical isolator market was valued at 5,966.07 million in 2021 and is projected to reach US$ 10,560.30 million by 2028; it is expected to grow at a CAGR of 8.5 % from 2021 to 2028. The growth of the pharmaceutical isolator market is attributed to factors such as an increase in investments by the pharmaceutical and biotechnology...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
The United States LED market was valued at USD 8.58 billion in 2020, and it is expected to reach a value of USD 15.23 billion by 2026, registering a CAGR of 9.85% over the forecast period (2021-2026). The outbreak of COVID-19 has led to a weakened growth of industrial output and the decline in light-manufacturing production across significant...
The global empty capsules market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical...
The implementation of track and trace solutions and technologies is an important strategy adopted by many manufacturing companies and regulatory bodies in recent years. The global track and trace solutions market is projected to reach USD 7.3 billion by 2026 from USD 4.1 billion in 2021, at a CAGR of 12.1% during the forecast period. Growth...
Germany - Healthcare, Regulatory and Reimbursement Landscape Summary The analyst has released its latest report, "Germany - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape...
Patent protected: Many industry operators are expected to raise prices on widely used specialty drugs Abstract Brand Name Pharmaceutical Manufacturing in the US Over the five years to 2019, the Brand Name Pharmaceutical Manufacturing industry in the United States experienced several new drug launches,...
The global pharmaceutical intermediates market is expected to reach US$ 37,290.33 million in 2028 from US$ 27,356.70 million in 2020. The market is estimated to grow with a CAGR of 3.95% during 2020-2028. Countries in Asia Pacific are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Low manufacturing...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.